Engaged Capital Reports New Position In Jamba, Inc. (JMBA)

Is Jamba, Inc. (NASDAQ:JMBA) a good investment? Glenn W. Welling seems to think so. Welling has recently initiated a position for his fund, Engaged Capital. As reported in a filing with the Securities and Exchange Commission, Engaged Capital has built a position that amasses 1.2 million shares or 7% of the total number of shares outstanding.

Jamba, Inc. (NASDAQ:JMBA)

Glenn J. Krevlin is also bullish on Jamba, Inc. (NASDAQ:JMBA), having boosted his fund’s stake in the company by 134% during the first quarter of 2014. In its latest 13F filing, Krevlin’s Glenhill Advisors has reported ownership of approximately 888,100 shares. Israel Englander has also become a fan of the company and has initiated a new position for his fund, Millennium Management. At the end of the first quarter, Millenium reported the holding of approximately 65,300 Jamba, Inc. (NASDAQ:JMBA) shares. Christopher Shackelton and Adam Gray are not so optimistic, though, and have chosen to limit their exposure to this stock. At the end of Q1, their fund, Coliseum Capital, has reported a 54% reduction in their stake to 483,400 shares.

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!